The conserved Mixed Lineage Leukaemia (MLL) complex deposits activating methyl marks on histone tails through a methyltransferase (MT) activity. Here we provide in vivo evidence that in addition to methylation, the C. elegans MLL-like complex can remove specific methyl marks linked to repression of transcription. This supports the proposed model in which the MLL complex orchestrates both the deposition and the removal of methyl marks to activate transcription. We have uncovered the MLL-like complex in a large-scale RNAi screen designed to identify attenuators of RAS signalling during vulval development. We have also found that the histone acetyltransferase complex, NuA4/TIP60, cooperates with the C. elegans MLL-like complex in the attenuation of RAS signalling. Critically, we show that both complexes regulate a common novel target and attenuator of RAS signalling, AJM-1 (Apical Junction Molecule-1). Therefore, the C. elegans MLL-like complex cooperates with the NuA4/TIP60 complex to regulate the expression of a novel effector, AJM-1.
Introduction
Chromatin structure plays a critical role during development due to its impact on the regulation of gene expression (Strahl and Allis, 2000) . The structure adopted by the chromatin is highly influenced by post-translational modifications such as phosphorylation, acetylation, ubiquitination, and methylation (Kouzarides, 2007) . Methylation of histone tails is an important modification, since it can regulate the recruitment of additional chromatin complexes. For example, methylation of lysine 4 on histone H3 can recruit the ATP-dependent nucleosome remodelling factor NURF to regulate transcription activation (Sims and Reinberg, 2006; Wysocka et al., 2006) , and methylation at lysine 27 can recruit Polycomb to repress transcription (Cao et al., 2005; Schuettengruber et al., 2007) . These methylation marks are crucial for the correct spatiotemporal expression of HOX genes in mice (Soshnikova and Duboule, 2009) , and are likely to play an equivalent role for other key developmental genes (Azuara et al., 2006; Bernstein et al., 2006) .
The histone H3 lysine 4 (H3K4) trimethylation (me3) mark is associated with activation of transcription, and can be deposited by H3K4 methyltransferases (MTs) of the Mixed Lineage Leukaemia (MLL) family (Ruthenburg et al., 2007) . On the other hand, the H3K27me3 mark correlates with repression of transcription (Cao et al., 2002) and can be removed by H3K27 demethylases (DMs) (Agger et al., 2007; Cloos et al., 2008; Hong et al., 2007; Jepsen et al., 2007; Lan et al., 2007; Lee et al., 2007; Swigut and Wysocka, 2007) . The identification of UTX during the biochemical purification of MLL2 led to the suggestion that H3K27DMs could function in association with the MLL complex De Santa et al., 2007) . However, the in vivo evidence that H3K27DMs are functionally associated with the MLL complex is limited (Agger et al., 2007; Lan et al., 2007; Lee et al., 2007; Soshnikova and Duboule, 2008; Swigut and Wysocka, 2007; Wysocka et al., 2005) . Nevertheless, it is an attractive possibility that the MLL complex, in addition to sustaining transcription, could relieve repression. For this reason, the MLL complex may stand at the apex of the molecular machinery that determines gene expression in many processes, such as stem cell development, cell cycle, segmental identity, hematopoiesis and the inflammation response (Bernstein et al., 2006; De Santa et al., 2007; Martinez and Cavalli, 2006; Mikkelsen et al., 2007; Okuda et al., 1996; Wang et al., 2008; Yu et al., 1995) .
In humans, there are at least six H3K4MTs of the MLL family (MLL1-4, and SET1a and b) (Ruthenburg et al., 2007) , and three H3K27DMs of the JmjC family (UTX, UTY, and JMJD3) (Cloos et al., 2008) . The MLL complex also includes the core complex (ASH2, WDR5 and RbBP5) that presents histone tails to H3K4MTs.
The C. elegans vulva system has been instrumental to identify and characterise components of multiple core signalling pathways, notably of the conserved EGFR/RAS/RAF/MAPK signalling pathway ( Fig. 1) (Sternberg, 2005) . It has also shed light on the molecular mechanisms involved in attenuation of RAS signalling (Sundaram, 2006) . Chromatin remodelling complexes have been shown to play an important role in the process of attenuation, notably via regulation of EGF expression (Cui et al., 2006 ) and regulation of negative or positive modulators of the RAS signalling cascade (Berset et al., 2005; Shaye and Greenwald, 2002; Singh and Han, 1995; Yoo et al., 2004) .
Herein, we have performed a large-scale RNAi screen in a sensitised genetic background (gap-1) to reveal attenuators of the RAS signalling pathway (Fig. 1) . This functional strategy has identified 39 candidates, including most of the components of the C. elegans MLL complex. We show that the MLL complex attenuates LET-60 RAS signalling. In addition, we have found that depletion of the histone acetyltransferase complex, NuA4/TIP60 (Ceol and Horvitz, 2004) , has the same effect as depleting the MLL complex. Interestingly, we have uncovered a novel common target, AJM-1 (Apical Junction Molecule-1). AJM-1 is important to maintain the integrity of epithelial cell junctions (Chisholm and Hardin, 2005; Koppen et al., 2001; Labouesse, 2006) . Importantly, AJM-1 also attenuates LET-60 RAS signalling, and hence acts as a novel downstream effector of the MLL and NuA4/TIP60 complexes. Collectively, these results support a model whereby the MLL complex cooperates with the NuA4/TIP60 complex to attenuate LET-60 RAS signalling via epigenetic regulation of ajm-1 expression.
Materials and methods

Strains and general maintenance
Strains used in this study were: N2, gap-1(ga133), rrf-3(pk1426); gap-1(ga133), lin-15A(n767), lin-15B(n744), let-60(n2021), let-60 (n2021);lin-15B(n744), let-60(n2021);lin-15A(n767), let-23(sy1);him-5 (e1490), unc-4(e120);arIs92[egl-17p::CFP::lacZ,unc-4(+),ttx-3p::GFP], Fig. 1 . Cell fate specification during vulval development. A) LIN-3 EGF is the inductive signal required for vulval fate adoption. It emanates from the anchor cell (AC) and activates the LET-60 RAS/LIN-45 RAF/MPK-1 MAPK signalling pathway by binding to its receptor, LET-23 EGFR (Hill and Sternberg, 1992; Kimble, 1981) . Three out of the six vulval precursor cells (VPCs: P5.p to P7.p) will acquire sufficient LET-60 RAS signalling levels to adopt the vulval fate (green and blue cells) (Sundaram, 2005) . These three VPCs will go through three rounds of cell divisions, except for two cells that will not proceed through the third division (black cells), generating the 22-cell vulva (Sulston and Horvitz, 1977) . The blue cells (primary cells) express higher levels of LET-60 RAS signalling than their flanking cells (secondary cells, green cells). The VPCs that do not adopt the vulval fate will fuse to the syncytial cell hyp7 (black nuclei), and are thought to express a basal level of LET-60 RAS signalling . B) Thresholds of LET-60 RAS signalling control vulval fate adoption. Mutants that decrease LET-60 RAS signalling have less than three VPCs adopting the vulval fate and produce the Vulvaless (Vul) phenotype. Mutants that increase LET-60 RAS signalling promote adoption of vulval fate in VPCs that would normally fuse to hyp7, hence they have more than three VPCs induced and produce the Muv phenotype (Ferguson et al., 1987; Sternberg, 2005; Sternberg and Horvitz, 1986, 1991) . The number in parentheses indicates the number of VPCs adopting the vulval fate (see Materials and methods). C) The LET-60 RAS/LIN-45 RAF/MPK-1 MAPK signalling cascade is conserved in VPCs and is attenuated by GAP-1 (GTPase Activating Protein). In the absence of GAP-1, RAS remains bound to GTP (active form) for longer (Sundaram, 2006) . D) Different LET-60 RAS levels in primary, secondary and tertiary vulval cells. The primary cells (blue nucleus) produce the highest level of LET-60 RAS signalling, because they receive more inductive signal, LIN-3 EGF, which will also stimulate the expression of Notch ligands (Chen and Greenwald, 2004) . The secondary cells (green nucleus) receive less inductive signal, and are in addition attenuated by the LIN-12 Notch signalling pathway (Sternberg, 2005; Sundaram, 2005) . Numerous attenuators of LET-60 RAS are activated by LIN-12 Notch signalling (Berset et al., 2001; Yoo et al., 2004) . The tertiary cells (white nucleus) are farther from the source of the ligand, and are thought to produce only a basal level of LET-60 RAS signalling.
unc-119(ed4);syIs78[ajm-1::GFP+unc-119(+)],dpy-20(e1282);him-5 (e1490);dels4[dpy-20(+)+ajm-1::GFP+lin-39TX::GFP (yeast DNA)], pha-1(e2123), dpy-5(e907);sEx13557[rCesT12D8.1(set-16)::GFP+ pCeh361], mys-1(n4075)/nT1[qIs51], tag-125(ok1417), unc-119(ed3) qaIs5 (Ex35[set-2::gfp+unc119(+)]),tag-125(ok1417);unc-4(e120); arIs92[egl-17p::CFP::lacZ, unc-4 (+), ttx-3p::GFP], pha-1(e2123) ukEx1 [set-16p::GFP, pha-1(+)], him-5(e1490)bxIs13 , and lin-12 (n137n460). Strains were maintained as described in Brenner (1974) .
RNAi experiments
The initial large-scale RNAi screen of chromosomes I, II and III was performed similarly to that described previously (Kamath et al., 2003) . Briefly, individual cultures were used to inoculate a single well on a six-well plate (Poulin et al., 2005) , between 4 and 8 synchronised rrf-3(pk1426);gap-1(ga133) L3-L4 stage worms were placed in each well and the plates were maintained at 20°C. The F 1 progeny were scored for the Mvp (multiple ventral protrusion) phenotype. RNAi clones causing N10% Mvp were selected for further analysis. 909 RNAi clones produced a very weak Mvp phenotype. This was considered a background that may reflect a weak genetic interaction between gap-1 and rrf-3. RNAi experiments using high confidence candidate clones were repeated initially using the gap-1(ga133) mutant strain, and were performed essentially as described above except that P 0 mothers were transferred when they started to lay eggs from well1 to well2 and the next day from well2 to well3. All RNAi clones were obtained from the Ahringer RNAi library (Kamath et al., 2003) with the exception of the ash-2 and mes-2 RNAi clones that are from the Vidal library (Rual et al., 2004) . All positive RNAi clones were verified by sequencing.
Vulval induction assay
Early L4 stage worms were mounted on 2% (w/v) agarose pads in 20 mM tetramisole (Sigma) and the vulva cell lineage was scored as described previously (Poulin et al., 2005; Sternberg and Horvitz, 1986) .
Quantitative RT-PCR
RNAi for quantitative RT-PCR experiments was performed essentially as described above with a few modifications. For L4440 empty vector (RNAi) and lin-15A(RNAi) experiments ∼1000 synchronised L3 staged lin-15B(n744) worms were placed on RNAi plates seeded with the respective RNAi clone. Worms fed set-16(RNAi) become partially sterile and so ∼ 3000 synchronised L3 staged lin-15B(n744) worms were used. The P 0 mothers were washed off the plates and bleached once they had been on RNAi for ∼54 h. The eggs were placed directly back onto RNAi plates seeded with the appropriate RNAi clone and the F1 worms harvested after 48 h. Total RNA was extracted using TRIzol (Invitrogen) and first strand cDNA synthesis was performed using the Superscript VILO cDNA Synthesis Kit (Invitrogen), according to the manufacturer's instructions. Quantitative RT-PCR was performed using the FastStart SYBR Green Master (ROX) mix (Roche) on an ABI Prism 7000 (Applied Biosystems). Three biological samples for each RNAi condition were prepared, and for every biological replicate a duplicate of 2 serial dilutions was analysed. act-1 was used as the internal reference for data normalisation. lin-3 levels were determined by comparing the unknown samples to a standard curve of known relative amounts.
Microinjection
To obtain the transgenic SET-16MLL::GFP strain, a 5.7 kb fragment (5 kb upstream to 0.7 kb downstream of the starting ATG) was cloned using Gateway® (Invitrogen) into pSB_GW::GFP. Following this 100 µg/ml of this construct along with 10 µg/ml pha-1(+) (Granato et al., 1994) was microinjected into the temperature sensitive mutant pha-1(e2123) using the method previously described (Mello et al., 1991) .
GFP assays
RNAi experiments for GFP analysis were performed as described above, by transferring the worms. ajm-1::GFP analysis was performed using mid to late L4 hermaphrodites, egl-5::GFP analysis was performed using young adult males and analysis of egl-17::CFP expression was performed as described (Yoo et al., 2004) .
Western blot analysis
RNAi was performed as described above. Whole worm protein extracts were prepared by initially removing the P 0 mothers from the final RNAi transfer well, and then harvesting the F 1 worms. A minimum volume of 20 µl pelleted worms was collected for each protein sample, washed in PBS buffer, boiled in 2× Sample buffer containing 100 mM DTT and sonicated. Antibodies against actin and histone H3 were used for normalisation. To ensure that the blot was performed within a linear range, we loaded serial two fold dilutions. We used anti-H3K4me3 (Abcam ab8580); anti-H3 (Abcam ab1791); anti-H3K27me3 (Upstate 07-449); and anti-actin (Abcam ab14128). Detection was performed using the ECL Plus Western blotting detection system according to the manufacturer's instructions (Amersham Biosciences).
Immunostaining RNAi was performed as described above. Briefly, immunostaining was performed using the freeze crack method (see Wormbook). About 100 worms per well were mounted on 0.3% poly-lysine coated three-well printed slides, methanol fixed for 15 min, and washed using PBS-Tween 0.2%. For staining, the slides were incubated with MH27, a mouse monoclonal antibody specific to AJM-1, at a dilution of 1:75 in PBS-Tween 0.2% at 4°C overnight. Following several washes, slides were incubated with DyLight 594-conjugated AffiniPure Goat Anti-mouse secondary antibody (Jackson ImmunoResearch cat. 115-515-146) at 1:100, for 4 h at 37°C.
Methylation assay
A C-terminal construct of SET-16 (residues Glu 2346 to Asn 2519) was sub-cloned into the GST fusion vector pTHREE-E for bacterial expression. The protein was isolated from the cell lysate on GST affinity resin (GE Healthcare), the tag was cleaved and the construct was purified to homogeneity by gel filtration. The purification buffer was 50 mM Tris-HCl, pH 7.5, 500 mM NaCl, 2 mM 2-mercaptoethanol and 10% v/v glycerol. Methyltransferase assays were carried out as described in Xiao et al. (2005) . Briefly, the purified enzyme (25 µM) was incubated with 0.5 mM S-adenosyl-L-methionine (SAM), 0.625 µM 3 H-SAM (GE Healthcare), and 1 mM H3 peptide substrate;
sequence ARTQTARYKSTGGKAPRY (University of Bristol). The incorporation of SAM was followed by separating the peptide from the unincorporated 3 H-SAM using "Sep Pak" C18 cartridges (Waters). The final salt concentration in the assays was 100 mM NaCl.
Results
Depletion of the MLL complex in the gap-1 background increases the number of VPCs adopting the vulval fate
In order to identify genes involved in attenuation of LET-60 RAS signalling, we performed a large-scale RNAi screen in a gap-1 (GTPase Activating Protein-1) mutant background. Deletion of gap-1 enhances the activity of LET-60 RAS and thereby creates a hypersensitive background for LET-60 RAS signalling, without affecting normal vulva development (Hajnal et al., 1997) . Only the loss of an additional attenuator will produce a change in cell fate specification (Yoo et al., 2004) .
To enable high throughput RNAi, we scored for Multiple ventral protrusions (Mvp). The Mvp phenotype, visible under a dissecting scope, can be caused by either migration defects or changes in cell fate, the latter suggesting excessive LET-60 RAS signalling. To distinguish between these two, we performed in vivo lineage analysis that allows us to assign the Multivulvae (Muv) phenotype, which corresponds to a change in cell fate specification. The stereotypical development of the vulva allows us to assign a score that corresponds to the number of Vulval Precursor Cells (VPCs) adopting the vulval fate (Fig. 1) . A score of three is normal, greater than three is Muv, and lower than three is Vulvaless (Vul) (Fig. 1 and Sternberg and Horvitz (1986) ).
Our RNAi screen covered the predicted genes from Chromosomes I, II, and III, roughly representing 40% of the C. elegans genome (Kamath et al., 2003) . We have identified 39 genes producing the Mvp phenotype (Gutierrez and Fisher et al., unpublished data) and focused our work on genes homologous to MLL, RbBP5, WDR5, and ASH2 (see Table 1 for nomenclature). All these were identified during the screen except for ash-2 that was not represented in the Ahringer library. We have performed lineage analysis of the vulva after separate RNAi of set-16 mll, rbbp-5, wdr-5, or ash-2 in the N2 wild type background. We did not detect any animals producing the Muv phenotype. However, we have found a significant percentage of Muv animals when the same experiment was performed in the gap-1 null background ( Fig. 2A) . Therefore, set-16 mll and the core complex interact genetically with gap-1 to produce a synthetic Muv phenotype.
Recently, it has been suggested that H3K27DMs could function within the MLL complex (Agger et al., 2007; Cho et al., 2007; Issaeva et al., 2007; Lan et al., 2007; Lee et al., 2007) . To test this, we inactivated by RNAi four predicted H3K27DMs (all on chromosome X) in the gap-1 background and screened for Mvp animals. Animals depleted of the UTX homologue, utx-1, produced the Mvp phenotype. These utx-1(RNAi); gap-1 animals were therefore further analysed and found to produce the Muv phenotype ( Fig. 2A) . utx-1(RNAi) in the wild type background shows a low frequency of Muv animals, which is increased five fold when the RNAi experiment is performed in the gap-1 background ( Fig. 2A) . These results show that both SET-16 MLL and UTX-1 are involved in preventing erroneous adoption of the vulval fate.
SET-16 MLL and UTX-1 regulate H3K4 trimethylation and H3K27 demethylation, respectively
We addressed whether SET-16 MLL and UTX-1 are required for trimethylation of H3K4 and demethylation of H3K27, respectively. We performed Western blots and found that there is less H3K4me3 in set-16(RNAi) animals (about 35% decrease) compared to control gfp (RNAi) animals, whilst no significant difference was observed with utx-1(RNAi) (Fig. 2B) . Further, there is more H3K27me3 in utx-1 (RNAi) animals compared to control animals (about 65% increase) (Fig. 2C) . To control the validity of our approach, we used extracts from mes-2(RNAi) animals. MES-2 is a homologue of EZH2 and a known H3K27MT (Ketel et al., 2005) . In mes-2(RNAi) animals there is less H3K27me3 compared to control (30% decrease), whilst no significant difference was observed in set-16(RNAi) animals (Fig. 2C) . We have also performed a quantitative analysis of H3K4me3 levels using extracts from the balanced set-16 mll knock out and found about 25% less H3K4me3 than in N2 worms ( Supplementary Fig. 1 ). Therefore, SET-16 MLL and UTX-1 regulate H3K4 methylation and H3K27 demethylation, respectively.
Trimethylation levels on H3K4 and H3K27 can toggle independently
An inverse correlation between H3K4me3 and H3K27me3 levels has been documented in the HOX gene clusters (Agger et al., 2007; Lan et al., 2007; Lee et al., 2007; Soshnikova and Duboule, 2009 ), but our global analysis suggests that low levels of H3K4me3 caused by the depletion of SET-16 MLL do not impact on H3K27me3 levels and vice versa, since depletion of UTX-1 does not affect H3K4me3 (Figs. 2B and  C) . This apparent discrepancy prompted us to test whether a wdr-5 deletion mutant shown to have reduced levels of H3K4me3 (Simonet et al., 2007) , would affect H3K27me3 levels. We observed the reported reduction in levels of H3K4me3 (Fig. 2D ), but the levels of H3K27me3 remained unaffected (Fig. 2E ). This suggests that WDR-5 is required for the trimethylation of H3K4, but not for the demethylation of H3K27me3. Using the same reasoning but testing the converse, we used mes-2/+ animals, in which H3K27me3 levels are reduced (about 50%) (Fig. 2E) , and found no alteration in H3K4me3 levels (Fig. 2D) . Therefore, we conclude that globally, levels of H3K4me3 can be altered without affecting the levels of H3K27me3, and vice versa.
SET-16 MLL is an H3K4MT
An analysis of the SET-16 sequence indicates that it is a member of the Set1/trithorax/MLL (KMT2) family of H3K4 methyltransferases. However, a more detailed analysis indicates that it most closely resembles the SET domain of human MLL2 (Fig. 3A) . Indeed when the domain architecture of the full length proteins are considered SET-16 shares the organisation of the human MLL2/3 and the Drosophila TRR proteins (Fig. 3B ) with characteristic adjacent FY-rich domains and lacking the taspase 1 recognition motif. In addition to SET-16 the only other member of the KMT2 family is SET-2 (Simonet et al., 2007) . Sequence analysis and domain architecture indicates that this is the worm homologue of the Set1/Set1A/B protein (Figs. 3A and B) . In C. elegans only one MLL-like protein, SET-16, and one Set1 protein, SET-2, are required for H3K4 mediated transcriptional regulation.
To confirm that SET-16 is an H3K4 methyltransferase we purified from bacteria the C-terminal SET domain and two small predicted helices representing the N-flanking domain. Methyltransferase assays were carried out with histone peptides which were either unmodified or mono-or di-methylated at the K4 site (Fig. 3C) . Robust activity was observed with the unmodified peptide indicating that the isolated domain has basal H3K4 monomethylase activity. We presume that as has been seen for the MLL1 isolated SET domain, SET-16 will require its cognate complex for activation and regulation (Southall et al., 2009 ). These results show that SET-16 MLL is an H3K4MT.
SET-16 MLL is expressed in all VPCs
Histone methyltransferases such as SET-16 and SET-2 are predicted to have broad patterns of expression, but since we uncovered a new function for SET-16 MLL during vulval development, we decided to examine closely its pattern of expression in this tissue. We found a high level of expression in the non-vulval descendants of the VPCs a wdr-5 is also known as swd-3. (vulval precursor cells) and a low level of expression in the vulval cells (Fig. 3D , SET-16 MLL::GFP). We also looked at the expression of SET-2::GFP, the other H3K4MT in C. elegans (Simonet et al., 2007) , even though set-2 does not appear to interact with gap-1 (Fig. 2A) . We found that it is expressed in all VPCs, as reported (Simonet et al., 2007) . We also noticed that SET-2::GFP expression is higher in the VPCs that will give rise to vulval cells, and lower in the non-vulval descendants. Hence, it appears that SET-16 MLL and SET-2 patterns of expression are complementary (Fig. 3D , SET-2::GFP). The SET-16 MLL pattern of expression correlates with its function as an attenuator of LET-60 RAS signalling. It is highly expressed in cells that have only basal level of LET-60 RAS signalling, and expressed at a low level in cells where LET-60 RAS signalling reaches higher levels.
SET-16 MLL synMuv activity requires LET-60 RAS signalling
The synthetic Muv (synMuv) genes prevent inappropriate adoption of vulval fate. They can be divided into three classes A, B, and C. Residues identical in all five sequences are shown in bold with a blue background, residues common to MLL1 or MLL2 are shown with a pale blue background and residues common to Set1A and SET-2 with a grey background. B) Domain organisation of SET-16 compared to the H3K4 methyltransferases in yeast, Drosophila and human. Like TRR, MLL2 and MLL3 the SET-16 protein has adjacent FYRN and FYRC domains and lacks taspase 1 recognition sequences. C) Methyltransferase activity of the isolated SET domain from SET-16 with histone H3K4 peptide substrate, either unmodified or carrying H3K4 mono-methyl or di-methyl modifications. D) SET-16 MLL and SET-2 have a complementary pattern of expression. Transgenic worms from a transcriptional fusion of SET-16 to GFP and a translational fusion of SET-2 to GFP were analysed for expression in VPCs' descendants after second division (see Fig. 1 ).
Only double mutants between each class produce the Muv phenotype (Fay and Yochem, 2007) . Synthetic Muv interactions between gap-1 and synMuv genes have been previously characterised (Ceol et al., 2006) , suggesting that the MLL complex might also produce synMuv interactions. We tested this by performing set-16 mll(RNAi) in lin-15A (synMuv A), lin-15B (synMuv B), and mys-1 (synMuv C) mutants, covering all three synMuv classes (Fay and Yochem, 2007) . We detected the Muv phenotype in all synMuv backgrounds (Fig. 4A) , suggesting that the MLL complex forms a promiscuous class of synMuv genes. Potential genetic interactions with synMuv genes have been tested in a previous study (Andersen and Horvitz, 2007) , but the lethality of the set-16 allele used precluded the vulval phenotype, which is bypassed here by our RNAi conditions ( Supplementary  Fig. 2 ).
The synMuv phenotype between A, B, and C has been shown to depend on LET-60 RAS signalling (Fay and Yochem, 2007; Ferguson et al., 1987; Huang et al., 1994; Lu and Horvitz, 1998; Poulin et al., 2005 ). Hence, we tested whether the SET-16 MLL synMuv activity also depends on LET-60 RAS signalling by using double mutants of a reduced function allele of let-60 ras (let-60 ras rf ) and lin-15A or lin-15B. In both double mutants let-60 ras rf suppressed the synMuv phenotype (Fig. 3A) . We conclude that the synMuv activity of the MLL complex is dependent on LET-60 RAS signalling.
The MLL complex and the NuA4/TIP60 complex can attenuate LET-60 RAS signalling in a wild type background
We next addressed whether the MLL complex could attenuate LET-60 RAS signalling in vivo without additional mutations such as in gap-1 or synMuv backgrounds. This 'non-redundant' activity can be measured using a reporter system (Yoo et al., 2004) . In this assay, egl-17::cfp expression is detected in the daughter and granddaughter cells of the VPCs expressing high levels of LET-60 RAS signalling (Fig. 1D) . In wild type, only the descendants of P6.p express egl-17:: cfp; the descendants of P5.p and P7.p (flanking secondary cells) are egl-17::cfp negative due to the low levels of LET-60 RAS signalling (Figs. 1 and 4B) (Yoo et al., 2004) .
We first monitored the levels of LET-60 RAS signalling when representative synMuv genes were absent (lin-15A (class A), lin-15B (class B), mys-1 and trr-1 (class C)). Mutants for lin-15A or lin-15B did not show persistent egl-17::cfp expression. In contrast, depletion of mys-1 or trr-1 (components of the NuA4/TIP60) caused persistent expression of egl-17::cfp in secondary cells (Fig. 4C) . We next performed separate RNAi of all the components of the MLL complex and found that all can cause persistent expression of egl-17::cfp (Figs. 4B and C) . Therefore, the MLL complex and the NuA4/TIP60 complex can attenuate LET-60 RAS signalling in a wild type background.
Excessive LET-60 Ras signalling is detected without an increase of lin-3 egf expression
An increase in LET-60 RAS signalling can be attributed to ectopic expression of lin-3 egf (Andersen and Horvitz, 2007; Cui et al., 2006) or extra anchor cell production (Phillips et al., 2007; Welchman et al., 2007) . Since an excess of LET-60 RAS signalling is detected in set-16 mll (RNAi) animals (Fig. 4C) , we tested whether ectopic expression of lin-3 egf could explain this effect. Using quantitative RT-PCR, we could not detect any significant changes in lin-3 egf expression between set-16 mll (RNAi) animals and gfp(RNAi) animals, even though the double mutant lin-15AB showed an increase in lin-3 egf expression ( Supplementary  Fig. 3 ) (Cui et al., 2006) . Since synMuv inactivations cause ectopic expression of lin-3 egf (Cui et al., 2006) , we tested whether in a synMuv context the double inactivation lin-15B and set-16 mll could affect lin-3 egf expression. We could not detect any difference in lin-3 egf expression compared to the negative control (Fig. 4D ).
Next, we tested whether a somatic gonadal defect that can sometimes cause extra anchor cell production could explain excessive LET-60 RAS signalling observed in the absence of set-16 mll. We assessed the number of anchor cells produced when the MLL complex was depleted using a transgenic strain carrying two markers: zmp-1::yfp and egl-17::cfp (Welchman et al., 2007) . zmp-1::yfp is an anchor cell marker, whereas egl-17::cfp allows us to confirm excessive LET-60 RAS signalling. We consistently observed only one anchor cell in animals depleted of set-16 mll (data not shown).
It has also been reported that VPCs can be a source of LIN-3 EGF (Dutt et al., 2004) . We tested whether specific lin-3 RNAi in VPCs (as described by Dutt et al.) could affect persistent expression of egl-17:: cfp in the absence of set-16 mll. Persistent egl-17::cfp remains similar to set-16(RNAi) indicating that LIN-3 EGF from the VPCs is not involved in this process (Fig. 4C) . Taken together, these results strongly suggest that excessive LET-60 RAS signalling is not caused by ectopic expression of lin-3 egf or production of multiple anchor cells.
The MLL complex and the NuA4/TIP60 complex regulate the expression of an apical junction marker, AJM-1 (Apical Junction Molecule-1)
The mammalian MLL complex has been shown to regulate expression of hox genes (Guenther et al., 2005; Milne et al., 2002; Milne et al., 2005; Schuettengruber et al., 2007; Yu et al., 1995) . We hypothesised that hox genes may also be regulated by the C. elegans MLL complex, and tested the effect of set-16 mll and utx-1 depletion on two hox genes: egl-5 and lin-39. We could only detect an effect on egl-5::gfp expression in males (see Supplementary Fig. 4) .
Interestingly, the lin-39::gfp strain additionally carries an integrated epithelial cell marker, ajm-1::gfp (Fig. 5B , no RNAi). AJM-1 is localised at the apical side of the vulval cells and whilst assessing the effect of depleting SET-16 MLL on lin-39::gfp worms, we noticed the disappearance of ajm-1::gfp expression (Fig. 5B) . We further characterised this effect using a different ajm-1::gfp transgenic strain that does not carry the lin-39::gfp transgene (see Materials and methods). Control animals expressed ajm-1 in the vulva at L4 stage (22-cell) as previously described (Fig. 5A and Sharma- Kishore et al. (1999) ). We tested the effect of loss-of-function mutations of lin-15A or lin-15B. Normal ajm-1::gfp expression was observed. However, inactivation by RNAi of either set-16 mll or utx-1 prevented or strongly reduced ajm-1 expression (Fig. 5A) . Interestingly, trr-1(RNAi), and mys-1(RNAi) animals showed a similar defect (Fig. 5A) . We verified these results using a mys-1 mutant and observed a reduction in ajm-1::gfp expression (Figs. 5A and B) . Pharyngeal expression of ajm-1::gfp was not affected (Supplementary Fig. 5 ). Importantly, regulation of ajm-1::gfp expression by either the MLL complex or the NuA4/TIP60 complex is unrelated to the transgene integration site, since lin-39:: gfp expression is not affected and can therefore be considered an internal control (Fig. 5B) . This regulation is also not a general activity of the synMuv genes, since lin-15A or lin-15B mutants did not reduce ajm-1::gfp expression.
We next performed immunostaining against AJM-1 to verify that the endogenous AJM-1 is also affected by the depletion of the MLL complex. The control animals all show a specific staining in the vulval cells at the first division stage as well as in the pharynx (SharmaKishore et al., 1999) . In contrast, the set-16 (RNAi) animals express AJM-1, but the staining appears thinner and fragmented (Fig. 5C) . We also performed the immunostaining at a later stage (after the second division), in which the control animals show typical localisation of AJM-1 in both the vulva and the pharynx. However, in set-16 (RNAi) treated worms AJM-1 expression remains fragmented or even absent in some cells (Fig. 5C) . These experiments validate our observations using the ajm-1::gfp transgene and strongly suggest that the MLL complex and the NuA4/TIP60 complex act as positive regulators of ajm-1 expression. A) Control animals exposed to the empty feeding vector, lin-15A, and lin-15B express normal levels of ajm-1::gfp. Animals exposed to RNAi targeting set-16 mll, utx-1, trr-1, or mys-1 as well as the mys-1 mutant lose AJM-1 expression to varying extents. B) Shown are representative pictures of the lin-39::gfp; ajm-1::gfp transgenic strain, and a DIC picture of the 22-cell vulva. Control animals express lin-39::gfp in a gradient, and ajm-1::gfp as a punctate and polarised signal. set-16 mll(RNAi) does not affect lin-39::gfp expression, but the punctate signal from ajm-1::gfp has disappeared. Also shown is the effect of mys-1 deletion on AJM-1 expression using a different ajm-1::gfp transgenic, but producing similar results. mys-1 heterozygote animals are not affected. C) SET-16 MLL regulates expression of endogenous AJM-1. Immunostaining using an antibody against AJM-1 shows that vulval AJM-1 expression is affected during knock down of set-16 mll. D) SET-16 MLL regulates mRNA levels of ajm-1. Progeny from a balanced set-16 mll strain express lower levels of ajm-1 than the parental balanced strain with set-16 mll. E) RNAi of ajm-1 produces the synMuv phenotype in the gap-1 background, but not in a lin-12(n137n460) cold-sensitive gain-of-function allele. Number of animals analysed is indicated on the right, with the average number of VPCs induced in Muv or Vul animals. F) AJM-1 can attenuate LET-60 RAS signalling similarly to SET-16 MLL or GAP-1 (data taken from Fig. 3 ).
SET-16 MLL regulates ajm-1 at the transcriptional level
We next addressed whether AJM-1 regulation is transcriptional using quantitative RT-PCR. Since animals most affected by the loss of SET-16 MLL do not reach the L3/L4 stages (see Supplementary Fig. 2 ), we opted for embryos obtained from the set-16 mll balanced strain. Of note, we could not detect an effect on ajm-1 expression using L4 set-16 (RNAi) animals. This is expected since ajm-1 expression in the pharynx (a major site of ajm-1 expression) is not affected under these conditions (Fig. 5C) . We compared that strain with the corresponding parental balanced strain and found that ajm-1 mRNA levels, in the set-16 mll strain, are reduced by ∼ 50% (Fig. 5D ). This strongly suggests that SET-16 MLL regulates ajm-1 expression at the level of transcription.
AJM-1 is an effector of the MLL complex and the NuA4/TIP60 complex
The identification of AJM-1 as a shared target between the MLL complex and the NuA4/TIP60 complex raised the question of whether regulation of AJM-1 expression is biologically significant. Since ajm-1 is on chromosome X and was not included in our screen, we tested whether ajm-1(RNAi) could produce the Muv phenotype in the gap-1 background. Indeed, we found that ajm-1 interacts with gap-1 to produce the Muv phenotype (Fig. 5E ). Since AJM-1 is important for integrity of epithelial junctions, we also tested whether ajm-1(RNAi) could affect Notch signalling. Depletion of ajm-1 in a lin-12 gain-offunction allele (Greenwald et al., 1983; Gupta et al., 2006; Komatsu et al., 2008) did not increase the frequency of the Muv phenotype (Fig. 5E ). We next addressed whether excessive LET-60 RAS signalling could be detected in animals depleted of ajm-1. We observed a persistent expression of egl-17::cfp in 18% of the population (Fig. 5F ). The phenotypes observed in ajm-1(RNAi) animals compared to the loss of the MLL complex or to the loss of the NuA4/TIP60 complex are qualitatively comparable, suggesting that the regulation of ajm-1 expression is a biologically significant process. Therefore, we propose that AJM-1 is a novel downstream effector of both the MLL and NuA4/ TIP60 complexes.
Discussion
Using a large-scale RNAi screen and the vulva system we have uncovered a C. elegans MLL-like complex that plays an important role in attenuation of LET-60 RAS signalling. We demonstrate that both the methyltransferase (SET-16 MLL) and the demethylase (UTX-1) of the C. elegans MLL complex attenuate LET-60 RAS signalling. We have also identified a novel target of the MLL complex, AJM-1. Critically, AJM-1 can prevent excessive LET-60 RAS signalling and act as a downstream effector of the MLL complex. In addition, we found that the MLL complex cooperates with the histone acetyltransferase complex, NuA4/TIP60, to ensure appropriate levels of LET-60 RAS signalling. Taken together, we have uncovered a novel chromatin to signalling pathway in which the MLL complex and the NuA4/TIP60 complex cooperate to attenuate LET-60 RAS signalling during vulva development via positive regulation of a novel effector, AJM-1 (Fig. 6 ).
SET-16 MLL and UTX-1 are part of the C. elegans MLL complex For the first time a histone methyltransferase and a demethylase of the MLL complex have been studied side-by-side. We show that both enzymes (SET-16 MLL and UTX-1) can prevent excessive LET-60 RAS signalling via a common mechanism (positive regulation of AJM-1 expression), and ensure appropriate posterior expression of the hox gene, egl-5. Based on these functional activities and on the biochemical properties of both enzymes, we propose that SET-16 MLL and UTX-1 are components of a C. elegans MLL-like complex. This will support the vertebrate model in which the MLL complex would orchestrate both deposition of the trimethyl (active) mark on H3K4, and removal of the trimethyl (repressive) mark on H3K27 (Agger et al., 2007; Cloos et al., 2008; Issaeva et al., 2007; Lan et al., 2007; Lee et al., 2007) .
Depletion of the MLL complex causes excessive LET-60 RAS signalling but not over expression of lin-3 egf
We have identified the MLL complex through genetic interactions with the known attenuator of the LET-60 RAS signalling pathway, gap-1 (Ceol et al., 2006; Hajnal et al., 1997; Yoo et al., 2004) . Other synMuv genes are known to interact with gap-1, but the molecular mechanism to produce that particular synMuv phenotype is still unknown (Ceol et al., 2006) . It is known, however, that double mutants between synMuv A and B genes cause over expression of lin-3 egf, which promotes abnormal adoption of the vulval fate (Cui et al., 2006) . We have found that set-16 mll can interact with class A and B synMuv genes, and therefore tested for over expression of lin-3 egf in this context. We could not detect over expression of lin-3 egf. Even though we cannot rule out that a small and undetectable amount of LIN-3 EGF is sufficient to cause the synMuv phenotype, it does suggest though that other mechanisms are involved in the synMuv process.
AJM-1 is an effector of the MLL complex and the NuA4/TIP60 complex Identification of the genes regulated by the MLL complex can indicate which biological function the complex is involved. From our functional data, we expected that the MLL complex, and the NuA4/ TIP60 complex would have common targets. Interestingly, we have found that AJM-1 is regulated by both the MLL complex, and the NuA4/TIP60 complex. The role that AJM-1 plays during vulva development has never been explored before this study. Surprisingly, we have found that ajm-1(RNAi) produces the synMuv phenotype in the gap-1 background, and causes excessive LET-60 RAS signalling in our egl-17::cfp assay. These phenotypes are reminiscent of the depletion of the MLL complex or of the NuA4/TIP60 complex. Therefore, it is likely that AJM-1 is an effector of both the MLL, and NuA4/TIP60 complexes. However, it is also likely that these complexes additionally regulate other attenuators of the LET-60 RAS signalling pathway. We predict that a number of these will interact Fig. 6 . The MLL and NuA4/TIP60 complexes are part of a chromatin to signalling pathway in which AJM-1 attenuates LET-60 RAS signalling. The MLL complex (in green) regulates the deposition of the activating methyl mark on H3K4 (green circles) and the removal of the repressive methyl mark on H3K27 (red circles). The combination of these marks could lead to the recruitment of the NuA4/TIP60 complex (in blue), which can augment histone tail acetylation and transcription rate. We postulate that these post-translational modifications on histone tails are critical in transcriptional regulation of ajm-1. Finally, AJM-1 (in red) attenuates LET-60 RAS signalling during vulval development.
with gap-1 to produce the synMuv phenotype, and could be identified in the future using our RNAi approach.
Concluding remarks
As hyperactivation of the RAS signalling cascade can lead to uncontrolled proliferation, and even cancer development, it is therefore important to decipher the mechanisms that the cell employs to prevent excessive RAS signalling. Using RNAi technology and gap-1 as a sensitive genetic background, we identified the MLL complex and the NuA4/ TIP60 complex in a novel chromatin to signalling pathway; these complexes converge onto AJM-1 which in turn acts as a novel attenuator of LET-60 RAS signalling (Fig. 6) . Interestingly, the connection between LET-60 RAS signalling and the MLL complex in C. elegans may be relevant to humans. Leukaemic patients harbouring MLL translocations and mutated RAS have a very poor prognosis (Liang et al., 2006; Mahgoub et al., 1998) , and a synthetic lethal screen for interaction with the KRAS oncogene has identified MLL (Luo et al., 2009 ).
